Publicación:
Distribución y Susceptibilidad de Cepas de Staphylococcus aureus Aisladas de Cinco Comunidades en Bogotá, Colombia, 2013.

dc.contributor.authorAfricano, Francisco Javierspa
dc.contributor.authorMéndez, Iván Albertospa
dc.contributor.authorHolguín, Diego Fabiánspa
dc.contributor.authorPachón, Diana Patriciaspa
dc.contributor.authorRojas, Nydia Alexandraspa
dc.date.accessioned2018-12-30T00:00:00Z
dc.date.accessioned2025-08-05T14:25:05Z
dc.date.available2018-12-30T00:00:00Z
dc.date.available2025-08-05T14:25:05Z
dc.date.issued2018-12-30
dc.description.abstractStaphylococcus aureus ha sido reconocido como uno de los microorganismos con resistencia a los antimicrobianos y mayor impacto incluso en infecciones adquiridas en la comunidad. Objetivo: El presente estudio pretende establecer la prevalencia y el perfil de susceptibilidad en aislamientos de Staphylococcus aureus de diferentes comunidades en la ciudad de Bogotá D.C., Colombia. Materiales y Métodos: 150 muestras de 5 diferentes comunidades fueron obtenidas mediante hisopado nasal y procesadas para identificación del S. aureus y su perfil de susceptibilidad. Resultados: De estudiantes de Medicina, amas de casa, personas de atención al público, manipuladores de alimentos y conductores de servicio público, se aislaron 43 (28,7%) cepas de S. aureus, 25 en mujeres (58%) y 18 en hombres (42%): 88,4% (38) se tipificaron como meticilino sensibles (SAMS) y 11,6% (5) como meticilino resistente (SAMR). Se encontró resistencia a la clindamicina (31,6% para los SAMS, 60% para los SAMR); al linezolid (50% en los SAMS, 80% para los SAMR) y para el trimethoprim sulfamethoxazol (18,9% para los SAMS, 60% para los SAMR). Conclusión: Bajo nivel de cepas de SAMS (25,3%) y SAMR (3,3%) en las comunidades evaluadas, en contraste a estudios en trabajadores de la salud (prevalencia para SAMR del 30%).spa
dc.description.abstractStaphylococcus aureus has been recognized as one of the microorganisms with antimicrobial resis-tance and even greater impact on community-acquired infections. Objective: This study aims to establish the prevalence and susceptibility profile ofStaphylococcus aureus isolates from different communities in the city of Bogota,Colombia. Materials and Methods: 150 samples from 5 different communities were obtained by nasal swabs and processed for identification of S. aureus and its susceptibilityprofile. Results: From medical students, housewives, people in customer service, food handlers and dri-vers of public service, we isolated 43 (28,7%) strains of S. aureus, 25 from women (58%) and 18 from men (42%): 88.4% (38) were typed as methicillin susceptible (MSSA) and 11.6% (5) as methicillin-resistant (MRSA). Resistance was found to clindamycin (31,6% for MSSA, 60% for MRSA);tolinezolid (50%inMSSA,80%forMRSA) andtrimethoprimsulfamethoxazole (18.9% for MSSA, 60% forMRSA). Conclusion: Low MSSA strains (25.3%) and MRSA (3.3%) in the communities evaluated, in contrast to studies in health care workers (30% prevalence for MRSA).eng
dc.format.mimetypeapplication/pdfspa
dc.identifier.doi10.26752/cuarzo.v24.n2.344
dc.identifier.eissn2500-7181
dc.identifier.issn0121-2133
dc.identifier.urihttps://repositorio.juanncorpas.edu.co/handle/001/399
dc.identifier.urlhttps://doi.org/10.26752/cuarzo.v24.n2.344
dc.language.isospaspa
dc.publisherFundación Universitaria Juan N. Corpasspa
dc.relation.bitstreamhttps://revistas.juanncorpas.edu.co/index.php/cuarzo/article/download/344/389
dc.relation.citationendpage12
dc.relation.citationissue2spa
dc.relation.citationstartpage7
dc.relation.citationvolume24spa
dc.relation.ispartofjournalRevista Cuarzospa
dc.relation.referencesMatlow A, Morris S. Control of antibiotic-resistant bacteria in the office and clinic. CMAJ 2009; 180(10):1021-1024.spa
dc.relation.referencesPlata K, Rosato A, Wegrzyn G. Staphylococcus aureus as an infectious agent: overview of biochemistry and molecular genetics of its pathogenicity. Acta Biochem Polon 2009; 56(4):597-612.spa
dc.relation.referencesPaul M, Kariv G, Goldberg E, Raskin M, Shaked H, Hazzan R, et al. Importance of appropriate empirical antibiotic therapy for methicillin- resistant Staphylococcus aureus bacteremia. J Antimicrob Chemother 2010; 65: 2658-2665.spa
dc.relation.referencesRehm S, Tice A. Staphylococcus aureus: Methicillin-Susceptible S. aureus to Methicillin-Resistant S. aureus and Vancomycin-Resistant S. aureus. Clin Infect Dis 2010; 51(S2):176-182.spa
dc.relation.referencesCui L, Iwamoto A, Lian J, Neoh H, Maruyama T, Horikawa Y, et al. A Novel Mechanism of Antibiotic Resistance Originating in Vancomycin-Intermediate Staphylococcus aureus. Antimicrob Agents Chemother 2006; 50(2):428-238.spa
dc.relation.referencesLiu C, Chambers H. Staphylococcus aureus with Heterogeneous Resistance to Vancomycin: Epidemiology, Clinical Significance, and Critical Assessment of Diagnostic Methods. Antimicrob Agents Chemother 2003; 47(10):3040-3045.spa
dc.relation.referencesSieradzki K, Leski T, Dick J, Borio L, Tomasz A. Evolution of a Vancomycin-Intermediate Staphylococcus aureus Strain In Vivo: Multiple Changes in the Antibiotic Resistance Phenotypes of a Single Lineage of Methicillin-Resistant S. aureus under the Impact of Antibiotics Administered for Chemotherapy. J Clin Microbiol 2003; 41(4):1687–1693.spa
dc.relation.referencesFrei C, Miller M, Lewis II J, Lawson K, Peddaiahgari R, Talbert R. Retrospective Cohort Study of Hospitalized Adults Treated With Vancomycin or Clindamycin for Methicillin-Resistant Staphylococcus aureus Skin Infections. Clin Ther. 2010; 32 (12):2024-2029.spa
dc.relation.referencesItani K, Dryden M, Bhattacharyya H, Kunkel M, Baruch A, Weigelt J. Efficacy and safety of linezolid versus vancomycin for the treatment of complicated skin and soft-tissue infections proven to be caused by methicillin-resistant Staphylococcus aureus. Am J Surg 2010; 199(6):804-816.spa
dc.relation.referencesBalkhair A, Al Muharrmi Z, Darwish L, Farhan H, Sallam M. Treatment of vancomycin-intermediate Staphylococcus aureus (VISA) endocarditis with linezolid. Int J Infect Dis 2010; 14:e227–e229.spa
dc.relation.referencesWang W, Lee S-Y, Chiueh T-S, Lu J-J. Molecular and Phenotypic Characteristics of Methicillin-Resistant and Vancomycin-Intermediate Staphylococcus aureus Isolates from Patients with Septic Arthritis. J Clin Microbiol 2009; 47(11):3617–3623.spa
dc.relation.referencesCui L, Tominaga E, Neoh H, Hiramatsu K. Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus. Antimicrob Agents Chemother. 2006; 50(3):1079–1082.spa
dc.relation.referencesAppleman M, Citron D. Efficacy of vancomycin and daptomycin against Staphylococcus aureus isolates collected over 29 years. Diagnostic Microbiol Infect Dis 2010; 66:441–444.spa
dc.relation.referencesHawser SP, Bouchillon SK, Hoban DJ, Dowzicky M, Babinchak T. Rising incidence of Staphylococcus aureus with reduced susceptibility to vancomycin and susceptibility to antibiotics: a global analysis 2004–2009. Intl J Antimicrob Agents 2011; 37:219–224.spa
dc.relation.referencesSosa L, Machuca M, Sosa C, González C. Infecciones por Staphylococcus aureus meticilino resitente en niños en Bucaramanga Colombia. Salud UIS 2010; 42: 248-255.spa
dc.relation.referencesVillalobos A, Díaz M, Barrero L, Rivera S, Henriquez D, Villegas M, Robledo C. Tendencias de los fenotipos de resistencia bacteriana en hospitales públicos y privados de alta complejidad de Colombia. Rev Panam Salud Publica.2011; 30(6):627-633.spa
dc.relation.referencesSpirandelli K, Mamizuka E, Gontijo P. Methicillin/Oxacillin-resistant Staphylococcus aureus as a hospital and public healt threat in Brazil. Brazilian J Infec Dis 2010; 14(1):71-76.spa
dc.relation.referencesMorell E, Balkin D. Methicillin–resistant Staphylococcus aureus: A pervasive pathogen highlights the need for new antimicrobial development. Yale J Biol Med 2010; 83:223-233.spa
dc.relation.referencesCáceres M. Frecuencia de portadores nasales de Staphylococcus aureus resistente a meticilina en personal de salud de hospitales de Nicaragua. Rev Panam Salud Pública 2011; 30(6):610-614.spa
dc.relation.referencesSeybold U, Schubert S, Bognera J, Hogardt M. Staphylococcus aureus infection following nasal colonization: an approach to rapid risk stratification in a university healthcare system. J Hosp Infect 2011; 79(1):297-301.spa
dc.relation.referencesRafee Y, Abdel-Haq N, Asmar B, Salimnia T, Vidaillac C, Rybak MJ, et al. Increased prevalence of methicillin-resistant Staphylococcus aureus nasal colonization in household contacts of children with community acquired disease. BMC Infect Dis 2012; 75(1):12-45.spa
dc.relation.referencesCreamer E, Dorrian S, Dolan A, Sherlock O, Fitzgerald-Hughes D, Thomas T, et al. When are the hands of healthcare workers positive for meticillin-resistant Staphylococcus aureus?. J Hosp Infect 2010; 75(1):107-111.spa
dc.relation.referencesHernández I, Toraño G, González M, González I. Staphylococcus aureus resistente a la meticilina: detección de portadores entre niños hospitalizados y niños sanos de la comunidad. Rev Cubana Med Trop 2003; 55(3):153-61.spa
dc.relation.referencesPalavecino E. Métodos recomendados para el estudio de susceptibilidad en Staphylococcus aureus, Staphylococcus coagulasa negativa y Staphylococcus saprophyticus: Nuevos puntos de corte e interpretación de resultados. Rev Chil Infect 2002; 19(2):119-124.spa
dc.relation.referencesMamani E, Luján D, Pajuelo G. Perfil de sensibilidad y resistencia de Staphylococcus aureus. Experiencia en el Hospital Nacional Hipólito Unanue. Annal Fac Med Lima 2006; 67(2):120-124.spa
dc.relation.referencesJaramillo S. Prueba Épsilon (Etest). Rev CES Med 1998; 12(1):34-41.spa
dc.relation.referencesClinical and Laboratory Standards Institute. Section 2C Performance standards for antimicrobial susceptibility testing; twenty-third informational supplement. 2013; 33(1):72-89.spa
dc.relation.referencesMalhotra-Kumar S, Haccuria K, Michiels M, Ieven M, Poyart C, Hryniewicz W, et al. MINIREVIEW. Current Trends in Rapid Diagnostics for Methicillin-Resistant Staphylococcus aureus and Glycopeptide-Resistant Enterococcus Species. J Clin Microbiol 2008; 46(5):1577–1587.spa
dc.relation.referencesMéndez I, Holguín D, Pachón D, Africano F, Gonzalez I, Rojas N. Prevalence and antimicrobial susceptibility of Staphylococcus aureus methicilin resistant isolated from medical students. Rev CES Med 2013; 27(1):21-30.spa
dc.relation.referencesFigueroa A, Arteaga M, Aguirre J, et al. Infections by methicillin-resistant Staphylococcus aureus Community-acquired (MRSA-CA) in the pediatric population in two hospitals in Popayan, Colombia. Rev Fac Cienc de la Salud. Univ del Cauca 2010; 12 (4): 8-13.spa
dc.relation.referencesLópez-Aguilera S, Goñi-Yeste M, Barrado L, et al. Colonización nasal por Staphylococcus aureus en estudiantes de medicina: importancia en la transmisión hospitalaria. Enferm Infecc Microbiol Clin. 2013; 31(8):500–505.spa
dc.relation.referencesEllis M, Griffith M, Jorgensen J, et al. Presence and Molecular Epidemiology of Virulence Factors in Methicillin-Resistant Staphylococcus aureus Strains Colonizing and Infecting Soldiers. J. Clin. Microbiol. 2009, 47(4):940-945.spa
dc.relation.referencesQu F, Cui E, Guo T, et al. Nasal Colonization of and Clonal Transmission of Methicillin-Susceptible Staphylococcus aureus among Chinese Military Volunteers. J. Clin. Microbiol. 2010, 48(1):64-69.spa
dc.relation.referencesHernández I, Toraño G, González M, et al. Staphylococcus aureus resistente a la meticilina: detección de portadores entre niños hospitalizados y niños sanos de la comunidad. Rev Cubana Med Trop 2003; 55(3):153-61.spa
dc.relation.referencesFosch S, Yones C, Trossero M, Grosso O, Nepote A. Portación nasal de Staphylococcus aureus en individuos de la comunidad: factores epidemiológicos. Acta Bioquím Clín Latinoam 2012; 46 (1): 59-67.spa
dc.relation.referencesLucet J, Regnier B, Screening and Decolonization: Does Methicillin-Susceptible Staphylococcus aureus Hold Lessons for Methicillin-Resistant S. aureus? Clin Infec Dis 2010; 51(5):585–590.spa
dc.relation.referencesEspinosa C, Romero M, Rincón G, Bohórquez M, Arámbula A. Portadores nasales de Staphylococcus aureus en personal que labora en un hospital de Santander. Salud UIS 2011; 43(2):111-117.spa
dc.relation.referencesMéndez I, Calixto O, Becerra W, Vásquez J, Bravo J, Pachón D. Microorganismos presentes en fonendoscopios, manos, cavidad oral y nasal de estudiantes de una facultad de Medicina. Rev MED. 2012. 20(1):90-100.spa
dc.relation.referencesGandia J, Benjumea Y, Mangones L, Villacob K, Sánchez L, Mosquera E. Prevalencia de Staphylococcus aureus meticilino resistente en estudiantes de medicina en la Universidad del Sinú. Reporte in Primer Encuentro nacional de semilleros de de investigación - facultades de Medicina, 2012 july 25-27, Bogotá, Colombia.spa
dc.rightsFrancisco Javier Africano Díaz, Iván Alberto Méndez Rodríguez, Diego Fabián Holguín Riaño, Diana Patricia Pachón Barina, Nydia Alexandra Rojas Ávila - 2018spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/spa
dc.sourcehttps://revistas.juanncorpas.edu.co/index.php/cuarzo/article/view/344spa
dc.subjectStaphylococcus aureusspa
dc.subjectComunidadspa
dc.subjectStaphylococcus aureus meticilino resistentespa
dc.titleDistribución y Susceptibilidad de Cepas de Staphylococcus aureus Aisladas de Cinco Comunidades en Bogotá, Colombia, 2013.spa
dc.title.translatedDistribution and susceptibility ofStaphylococcus au-reus strains isolated from five communities in Bogotá, Colombia,2013eng
dc.typeArtículo de revistaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.localJournal articleeng
dc.type.redcolhttp://purl.org/redcol/resource_type/ARTREFspa
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dspace.entity.typePublicationspa

Archivos